These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 9545002)
1. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis. Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002 [TBL] [Abstract][Full Text] [Related]
2. Improved renal function in children with cystinosis treated with cysteamine. Markello TC; Bernardini IM; Gahl WA N Engl J Med; 1993 Apr; 328(16):1157-62. PubMed ID: 8455682 [TBL] [Abstract][Full Text] [Related]
3. Cysteamine therapy for children with nephropathic cystinosis. Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461 [TBL] [Abstract][Full Text] [Related]
4. Nephropathic cystinosis: effect of long-term cysteamine therapy. Proesmans W; Baten E; Hoogmartens J; Bruyneel P Clin Nephrol; 1987 Jun; 27(6):309-12. PubMed ID: 3608256 [TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone treatment on pubertal growth in a boy with cystinosis and growth failure after renal transplantation. Haffner D; Wühl E; Nissel R; Schaefer F; Mehls O Br J Clin Pract Suppl; 1996 Aug; 85():7-9. PubMed ID: 8995018 [TBL] [Abstract][Full Text] [Related]
6. Acquired structural genitourinary abnormalities contributing to deterioration of renal function in older patients with nephropathic cystinosis. Strife CF; Strife JL; Wacksman J Pediatrics; 1991 Dec; 88(6):1238-41. PubMed ID: 1956743 [TBL] [Abstract][Full Text] [Related]
7. Predictors of the response to growth hormone in short prepubertal children post-renal transplant. German Study Group for Growth Hormone Treatment in Children Post Renal Transplantation Study Group Members. Tönshoff B; Haffner D; Albers N; Offner G; Mehls O Br J Clin Pract Suppl; 1996 Aug; 85():34-7. PubMed ID: 8995027 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of cystinosis using cysteamine]. Broyer M; Tete MJ Ann Pediatr (Paris); 1990 Feb; 37(2):91-3. PubMed ID: 2321906 [TBL] [Abstract][Full Text] [Related]
9. Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Manz F; Gretz N Pediatr Nephrol; 1994 Aug; 8(4):466-71. PubMed ID: 7947039 [TBL] [Abstract][Full Text] [Related]
10. Report of a Brazilian multicenter study on nephropathic cystinosis. Vaisbich MH; Koch VH Nephron Clin Pract; 2010; 114(1):c12-8. PubMed ID: 19816039 [TBL] [Abstract][Full Text] [Related]
11. Effects of cysteamine therapy in nephropathic cystinosis. Yudkoff M; Foreman JW; Segal S N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733 [TBL] [Abstract][Full Text] [Related]
12. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Wühl E; Haffner D; Tönshoff B; Mehls O Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375 [TBL] [Abstract][Full Text] [Related]
13. [The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis]. Jedrzejowski A; Dyras P; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Roszkowska-Blaim M; Pietrzyk JA; Gałazka B Pol Merkur Lekarski; 2002 Sep; 13(75):191-5. PubMed ID: 12474568 [TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. Andersson HC; Markello T; Schneider JA; Gahl WA J Pediatr; 1992 May; 120(5):716-20. PubMed ID: 1578305 [TBL] [Abstract][Full Text] [Related]
15. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy]. Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment of growth failure among children with renal transplants. Jabs K; Van Dop C; Harmon WE Kidney Int Suppl; 1993 Oct; 43():S71-5. PubMed ID: 8246374 [TBL] [Abstract][Full Text] [Related]
17. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial. Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ; Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275 [TBL] [Abstract][Full Text] [Related]
18. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies]. Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971 [TBL] [Abstract][Full Text] [Related]
19. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. Kimonis VE; Troendle J; Rose SR; Yang ML; Markello TC; Gahl WA J Clin Endocrinol Metab; 1995 Nov; 80(11):3257-61. PubMed ID: 7593434 [TBL] [Abstract][Full Text] [Related]
20. Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Gahl WA; Schneider JA; Schulman JD; Thoene JG; Reed GF Pediatr Nephrol; 1990 Mar; 4(2):129-35. PubMed ID: 2397178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]